Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

China Jo-Jo Drugstores

Nasdaq:CJJD
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CJJD
Nasdaq
$58M
Market Cap
  1. Home
  2. US
  3. Consumer Retailing
Company description

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People’s Republic of China. The last earnings update was 46 days ago. More info.


Add to Portfolio Compare Print
CJJD Share Price and Events
7 Day Returns
14.2%
NasdaqCM:CJJD
-1.1%
US Consumer Retailing
12.5%
US Market
1 Year Returns
-37.2%
NasdaqCM:CJJD
4%
US Consumer Retailing
-12.7%
US Market
CJJD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
China Jo-Jo Drugstores (CJJD) 14.2% 7.3% -2.7% -37.2% 0.6% -43.3%
US Consumer Retailing -1.1% -1.7% -11.8% 4% 26.1% 18.1%
US Market 12.5% -14.7% -21.5% -12.7% 5.4% 17.5%
1 Year Return vs Industry and Market
  • CJJD underperformed the Consumer Retailing industry which returned 4% over the past year.
  • CJJD underperformed the Market in United States of America which returned -12.7% over the past year.
Price Volatility
CJJD
Industry
5yr Volatility vs Market

Value

 Is China Jo-Jo Drugstores undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for China Jo-Jo Drugstores. This is due to cash flow or dividend data being unavailable. The share price is $1.77.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for China Jo-Jo Drugstores's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are China Jo-Jo Drugstores's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:CJJD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-0.01
NasdaqCM:CJJD Share Price ** NasdaqCM (2020-03-30) in USD $1.77
United States of America Consumer Retailing Industry PE Ratio Median Figure of 22 Publicly-Listed Consumer Retailing Companies 15.4x
United States of America Market PE Ratio Median Figure of 2,942 Publicly-Listed Companies 12.96x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of China Jo-Jo Drugstores.

NasdaqCM:CJJD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:CJJD Share Price ÷ EPS (both in USD)

= 1.77 ÷ -0.01

-240.26x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Jo-Jo Drugstores is loss making, we can't compare its value to the US Consumer Retailing industry average.
  • China Jo-Jo Drugstores is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does China Jo-Jo Drugstores's expected growth come at a high price?
Raw Data
NasdaqCM:CJJD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -240.26x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Consumer Retailing Industry PEG Ratio Median Figure of 13 Publicly-Listed Consumer Retailing Companies 2.37x
United States of America Market PEG Ratio Median Figure of 2,006 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for China Jo-Jo Drugstores, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on China Jo-Jo Drugstores's assets?
Raw Data
NasdaqCM:CJJD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $0.73
NasdaqCM:CJJD Share Price * NasdaqCM (2020-03-30) in USD $1.77
United States of America Consumer Retailing Industry PB Ratio Median Figure of 29 Publicly-Listed Consumer Retailing Companies 1.12x
United States of America Market PB Ratio Median Figure of 5,143 Publicly-Listed Companies 1.26x
NasdaqCM:CJJD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:CJJD Share Price ÷ Book Value per Share (both in USD)

= 1.77 ÷ 0.73

2.42x

* Primary Listing of China Jo-Jo Drugstores.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Jo-Jo Drugstores is overvalued based on assets compared to the US Consumer Retailing industry average.
X
Value checks
We assess China Jo-Jo Drugstores's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. China Jo-Jo Drugstores has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is China Jo-Jo Drugstores expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as China Jo-Jo Drugstores has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
5%
Expected Consumer Retailing industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is China Jo-Jo Drugstores expected to grow at an attractive rate?
  • Unable to compare China Jo-Jo Drugstores's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare China Jo-Jo Drugstores's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare China Jo-Jo Drugstores's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:CJJD Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 5%
United States of America Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:CJJD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:CJJD Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 113 -7 0
2019-09-30 111 -2 -2
2019-06-30 110 -11 -3
2019-03-31 108 -6 -1
2018-12-31 105 -3 -17
2018-09-30 101 -4 -17
2018-06-30 97 -1 -16
2018-03-31 96 -2 -17
2017-12-31 92 -6 -9
2017-09-30 86 1 -8
2017-06-30 82 1 -7
2017-03-31 81 2 -6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if China Jo-Jo Drugstores is high growth as no earnings estimate data is available.
  • Unable to determine if China Jo-Jo Drugstores is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:CJJD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from China Jo-Jo Drugstores Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CJJD Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -0.01
2019-09-30 -0.08
2019-06-30 -0.09
2019-03-31 -0.05
2018-12-31 -0.60
2018-09-30 -0.62
2018-06-30 -0.62
2018-03-31 -0.68
2017-12-31 -0.37
2017-09-30 -0.35
2017-06-30 -0.32
2017-03-31 -0.28

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if China Jo-Jo Drugstores will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine China Jo-Jo Drugstores's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. China Jo-Jo Drugstores's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Consumer Retailing companies here
  3. China Jo-Jo Drugstores's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess China Jo-Jo Drugstores's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
China Jo-Jo Drugstores has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has China Jo-Jo Drugstores performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare China Jo-Jo Drugstores's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • China Jo-Jo Drugstores does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare China Jo-Jo Drugstores's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare China Jo-Jo Drugstores's 1-year growth to the US Consumer Retailing industry average as it is not currently profitable.
Earnings and Revenue History
China Jo-Jo Drugstores's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from China Jo-Jo Drugstores Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CJJD Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 113.45 -0.23 26.96
2019-09-30 111.00 -2.44 29.49
2019-06-30 110.06 -2.81 28.62
2019-03-31 107.55 -1.32 25.98
2018-12-31 105.24 -16.76 38.84
2018-09-30 101.13 -16.71 37.34
2018-06-30 97.21 -16.29 37.10
2018-03-31 96.11 -17.06 36.56
2017-12-31 91.77 -9.25 27.19
2017-09-30 85.56 -8.46 24.45
2017-06-30 82.23 -7.19 21.65
2017-03-31 81.50 -5.64 20.61
2016-12-31 82.18 0.20 18.14
2016-09-30 86.27 0.41 18.27
2016-06-30 88.69 0.47 18.12
2016-03-31 89.07 0.45 17.54
2015-12-31 89.27 0.76 15.82
2015-09-30 85.88 1.50 13.48
2015-06-30 81.75 1.31 11.90
2015-03-31 76.90 0.86 10.73
2014-12-31 72.35 -15.54 16.46
2014-09-30 68.87 -24.41 22.69
2014-06-30 67.28 -24.92 23.49
2014-03-31 66.15 -25.36 24.96
2013-12-31 64.41 -19.92 29.45
2013-09-30 62.18 -14.67 26.89
2013-06-30 71.98 -15.66 26.83

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if China Jo-Jo Drugstores has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if China Jo-Jo Drugstores has efficiently used its assets last year compared to the US Consumer Retailing industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if China Jo-Jo Drugstores improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess China Jo-Jo Drugstores's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
China Jo-Jo Drugstores has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is China Jo-Jo Drugstores's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up China Jo-Jo Drugstores's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • China Jo-Jo Drugstores is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • China Jo-Jo Drugstores's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of China Jo-Jo Drugstores's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from China Jo-Jo Drugstores Company Filings, last reported 3 months ago.

NasdaqCM:CJJD Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 22.43 29.21 12.02
2019-09-30 21.62 22.36 17.55
2019-06-30 23.50 24.90 8.50
2019-03-31 16.97 26.75 9.50
2018-12-31 13.70 26.00 5.80
2018-09-30 15.27 16.24 7.08
2018-06-30 18.22 14.31 9.08
2018-03-31 18.86 20.03 15.31
2017-12-31 25.11 20.06 8.63
2017-09-30 25.86 13.63 17.00
2017-06-30 26.05 14.03 14.52
2017-03-31 26.66 13.62 18.45
2016-12-31 20.48 13.17 4.64
2016-09-30 20.23 13.40 8.35
2016-06-30 19.48 13.24 5.51
2016-03-31 19.32 19.25 7.14
2015-12-31 19.01 18.98 4.34
2015-09-30 19.63 19.13 6.71
2015-06-30 17.52 21.82 2.96
2015-03-31 17.23 17.94 5.33
2014-12-31 15.69 16.58 1.73
2014-09-30 15.11 12.80 7.35
2014-06-30 14.14 11.53 3.38
2014-03-31 14.36 10.66 4.45
2013-12-31 29.81 8.21 3.11
2013-09-30 37.89 7.29 6.30
2013-06-30 38.15 7.30 2.71
  • China Jo-Jo Drugstores's level of debt (130.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (105.7% vs 130.2% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • China Jo-Jo Drugstores has sufficient cash runway for 1.4 years based on current free cash flow.
  • China Jo-Jo Drugstores has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 48.2% each year.
X
Financial health checks
We assess China Jo-Jo Drugstores's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. China Jo-Jo Drugstores has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is China Jo-Jo Drugstores's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from China Jo-Jo Drugstores dividends.
If you bought $2,000 of China Jo-Jo Drugstores shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate China Jo-Jo Drugstores's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate China Jo-Jo Drugstores's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:CJJD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 13 Stocks 2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1946 Stocks 3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as China Jo-Jo Drugstores has not reported any payouts.
  • Unable to verify if China Jo-Jo Drugstores's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of China Jo-Jo Drugstores's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as China Jo-Jo Drugstores has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess China Jo-Jo Drugstores's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can China Jo-Jo Drugstores afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. China Jo-Jo Drugstores has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of China Jo-Jo Drugstores's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Lei Liu
COMPENSATION $53,676
AGE 55
TENURE AS CEO 10.4 years
CEO Bio

Mr. Liu Lei, M.D., has been the Chief Executive Officer of China Jo-Jo Drugstores, Inc. since September 17, 2009. He is one of the three founders of HJ Group. From December 1997 to August 2003, Mr. Liu worked in Tai He Drugstore as a general manager. From September 1992 to November 1997, Mr. Liu was an administration official of Hangzhou Medical Junior College, his alma mater, where he was also a researcher and an anatomy instructor from September 1983 to July 1992. He has been the Chairman of Board and Director of China Jo-Jo Drugstores, Inc. since September 17, 2009. He has been an Executive Director of Jiuzhou Pharmacy since September 2003 and the supervising director of Jiuzhou Service since November 2005. Mr. Liu has been a licensed researcher in the PRC since September 1988. He is a Graduate of Hangzhou Medical College.

CEO Compensation
  • Lei's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Lei's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the China Jo-Jo Drugstores management team in years:

5
Average Tenure
44
Average Age
  • The average tenure for the China Jo-Jo Drugstores management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Lei Liu

TITLE
Chairman & CEO
COMPENSATION
$54K
AGE
55
TENURE
10.4 yrs

Frank Zhao

TITLE
Chief Financial Officer
COMPENSATION
$88K
AGE
43
TENURE
8.6 yrs

Wei Hu

TITLE
Chief Operating Officer
AGE
45
TENURE
1.3 yrs

Steve Liu

TITLE
Investor Relations Director

Yan Liu

TITLE
Secretary
AGE
28
TENURE
1.4 yrs
Board of Directors Tenure

Average tenure and age of the China Jo-Jo Drugstores board of directors in years:

4.5
Average Tenure
54
Average Age
  • The tenure for the China Jo-Jo Drugstores board of directors is about average.
Board of Directors

Lei Liu

TITLE
Chairman & CEO
COMPENSATION
$54K
AGE
55
TENURE
10.4 yrs

Genghua Gu

TITLE
Independent Director
COMPENSATION
$6K
AGE
69
TENURE
6 yrs

Caroline Wang

TITLE
Independent Director
COMPENSATION
$12K
AGE
32
TENURE
3 yrs

Jiangliang He

TITLE
Independent Director
COMPENSATION
$3K
AGE
56
TENURE
1.4 yrs

Li Qi

TITLE
Director
COMPENSATION
$45K
AGE
47
TENURE
10.4 yrs

Pingfan Wu

TITLE
Independent Director
COMPENSATION
$4K
AGE
53
TENURE
1.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess China Jo-Jo Drugstores's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. China Jo-Jo Drugstores has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

The China Jo-Jo Drugstores (NASDAQ:CJJD) Share Price Is Down 45% So Some Shareholders Are Getting Worried

Check out our latest analysis for China Jo-Jo Drugstores Because China Jo-Jo Drugstores is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … Over three years, China Jo-Jo Drugstores grew revenue at 10% per year. … It might be well worthwhile taking a look at our free report on China Jo-Jo Drugstores's earnings, revenue and cash flow.

Simply Wall St -

Do Insiders Own Shares In China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD)?

View our latest analysis for China Jo-Jo Drugstores NasdaqCM:CJJD Ownership Summary, July 18th 2019 What Does The Institutional Ownership Tell Us About China Jo-Jo Drugstores? … Insider Ownership Of China Jo-Jo Drugstores The definition of company insiders can be subjective, and does vary between jurisdictions. … But other times, private equity is selling out, having taking the company public.

Simply Wall St -

How Should Investors React To China Jo-Jo Drugstores, Inc.'s (NASDAQ:CJJD) CEO Pay?

Check out our latest analysis for China Jo-Jo Drugstores How Does Lei Liu's Compensation Compare With Similar Sized Companies? … With a three year total loss of 33%, China Jo-Jo Drugstores, Inc. … We compared the total CEO remuneration paid by China Jo-Jo Drugstores, Inc., and compared it to remuneration at a group of similar sized companies.

Simply Wall St -

Investors Who Bought China Jo-Jo Drugstores (NASDAQ:CJJD) Shares Five Years Ago Are Now Down 28%

So we wouldn't blame long term China Jo-Jo Drugstores, Inc. … China Jo-Jo Drugstores isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. … Over five years, China Jo-Jo Drugstores grew its revenue at 8.0% per year.

Simply Wall St -

Does China Jo-Jo Drugstores, Inc.'s (NASDAQ:CJJD) CEO Pay Reflect Performance?

First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Lei Liu's Compensation Compare With Similar Sized Companies. … We examined a group of similar sized companies, with market capitalizations of below US$200m

Simply Wall St -

What You Must Know About China Jo-Jo Drugstores, Inc.'s (NASDAQ:CJJD) Financial Strength

Investors are always looking for growth in small-cap stocks like China Jo-Jo Drugstores, Inc. … However, an important fact which most ignore is: how financially healthy is the business? … Companies operating in the Consumer Retailing industry facing headwinds from current disruption,.

Simply Wall St -

Is China Jo-Jo Drugstores Inc's (NASDAQ:CJJD) CEO Paid At A Competitive Rate?

How Does Lei Liu's Compensation Compare With Similar Sized Companies. … Our data indicates that China Jo-Jo Drugstores Inc is worth US$65m, and total annual CEO compensation is US$2.5m. … We examined a group of similar sized companies, with market capitalizations of below US$200m

Simply Wall St -

Are China Jo-Jo Drugstores Inc's (NASDAQ:CJJD) Interest Costs Too High?

Investors are always looking for growth in small-cap stocks like China Jo-Jo Drugstores Inc (NASDAQ:CJJD), with a market cap of US$35.59m. … However, an important fact which most ignore is: how financially healthy is the business? … Companies operating in the Consumer Retailing industry facing headwinds from current disruption,.

Simply Wall St -

China Jo-Jo Drugstores Inc (NASDAQ:CJJD): Time For A Financial Health Check

Investors are always looking for growth in small-cap stocks like China Jo-Jo Drugstores Inc (NASDAQ:CJJD), with a market cap of US$37.60m. … However, an important fact which most ignore is: how financially healthy is the business? … Companies operating in the Consumer Retailing industry facing headwinds from current disruption,

Simply Wall St -

How Does China Jo-Jo Drugstores Inc (NASDAQ:CJJD) Affect Your Portfolio Returns?

CJJD’s beta indicates it is a stock that investors may find valuable if they want to reduce the overall market risk exposure of their stock portfolio. … Therefore, investors can expect a high beta associated with the size of CJJD, but a lower beta given the nature of the industry it operates in. … I test CJJD’s ratio of fixed assets to total assets in order to determine how high the risk is associated with this type of constraint.

Simply Wall St -

Company Info

Description

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People’s Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates dada360.com, an online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms, such as Tmall, JD.com, and Amazon.com. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2019, it had 121 retail pharmacies under the Jiuzhou Grand Pharmacy name; and 8 drugstores controlled by Hangzhou Jiuzhou Grand Pharmacy. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People’s Republic of China.

Details
Name: China Jo-Jo Drugstores, Inc.
CJJD
Exchange: NasdaqCM
Founded:
$58,298,111
32,936,786
Website: http://www.jiuzhou-drugstore.com
Address: China Jo-Jo Drugstores, Inc.
Hai Wai Hai Tongxin Mansion,
Floor 6,
Hangzhou,
Zhejiang Province, 310008,
China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM CJJD Common Shares Nasdaq Capital Market US USD 18. Sep 2009
DB 04CN Common Shares Deutsche Boerse AG DE EUR 18. Sep 2009
Number of employees
Current staff
Staff numbers
1,049
China Jo-Jo Drugstores employees.
Industry
Drug Retail
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 02:13
End of day share price update: 2020/03/30 00:00
Last earnings filing: 2020/02/14
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.